France
i-SEP, founded in 2015 in Nantes, France, is a specialized medtech company operating within the Biotechnology sector. Their mission, as reflected in their slogan, "We believe in safer blood," focuses on autotransfusion and Patient Blood Management. The company has developed and patented an innovative technology for the recovery and separation of blood components, which brings substantial improvements over existing solutions, particularly enhancing blood quality.
The organization's approach involves close collaborations with specialized clinicians, aiming to boost patient benefits, streamline physician workflows, and minimize healthcare costs. The technology not only benefits patients but also appeals to stakeholders by improving cost-efficiency metrics in medical practices.
i-SEP last secured a €1.23M Venture Round - I investment on 05 April 2017, led by Go Capital. The founding team includes Dr. Francis Gadrat, Bertrand Chastenet, and Sylvain Picot, bringing a strong mix of medical expertise, business acumen, and innovation leadership to the company.
